MAS1 and head and neck squamous cell carcinoma: Mechanistically, the way the heptapeptide can initiate its beneficial effects might be unclear from our expression profile of Mas and MrgD in human HNSCC tissue, since we found small amounts of Mas and/or MrgD expression in areas of human tumor tissue corresponding to the areas of papilloma formation in our preclinical mouse model.